09/12/2025
New Study Alert!
Professor Giorgia della Rocca co-authored a study on the endocannabinoid system. You might recognize her from one of our recent Italian-language podcasts, available on our YouTube channel.
The study is titled, "The Role of the Endocannabinoid System in Oncology and the Potential Use of Cannabis Derivatives for Cancer Management in Companion Animals."
Here's how VCS Board Member, Dr. Elena Battaglia, summarizes it: "The article is a summary of various studies concerning cannabinoids use in oncology. It analyzes the interaction between cannabinoids and ECS in neoplastic diseases, the antitumor mechanisms of cannabinoids and the synergy with anti-tumor drugs."
Here's the study's Simple Summary:
Companion animals are more and more becoming considered family members, and their owners wish to offer them the same level of cure and care expected for a human being. The long life expectancy of dogs and cats is associated with new challenges: veterinary medicine must be prepared to diagnose and treat neoplastic pathology with the same high-standard procedures that are currently used in human medicine. Chemotherapies aim to prolong as long as possible the life of companion animals affected by cancer, but several side effects can be experienced. Thus, an increasing interest in alternative and complementary treatments has arisen in the last years. Among a wide array, cannabinoids seem to be a promising tool to be included in therapeutic protocols since their administration could assist traditional chemotherapeutic agents, promoting a more successful antineoplastic effect, prolonging the prognosis, and contributing to patient well-being thanks to pain relief. According to all the aforementioned factors, the present review aims to summarize how the endocannabinoid system and phytocannabinoids interact in the complex process of carcinogenesis, exploring current therapeutical applications and future perspectives in veterinary oncology.
Read the full study on mdpi.com